Home > Financial Ratios > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
Core EBITDA Margin

    Back to All Ratios
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for STRIDES PHARMA SCIENCE
Please provide your vote to see the results

STRIDES PHARMA SCIENCE Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Margin(%) 11.9511.259.406.17-0.40

What is the latest Core EBITDA Margin ratio of STRIDES PHARMA SCIENCE ?

The latest Core EBITDA Margin ratio of STRIDES PHARMA SCIENCE is 11.95 based on Mar2026 Consolidated results.
Year Core EBITDA Margin
Mar202611.95
Mar202511.25
Mar20249.40
Mar20236.17
Mar2022-0.40

How is Core EBITDA Margin of STRIDES PHARMA SCIENCE Trending?

Years Core EBITDA Margin % Change
Mar2026 11.95
6.22
Mar2025 11.25
19.68
Mar2024 9.4
52.35
Mar2023 6.17
Positive
Mar2022 -0.4 -

Other Financial Ratios of STRIDES PHARMA SCIENCE


Compare Core EBITDA Margin ratio of peers of STRIDES PHARMA SCIENCE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE ₹9,782.0 Cr -2.1% -7.9% 27.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,427.0 Cr 0.2% -4.1% 5.5% Stock Analytics
DIVIS LABORATORIES ₹239,982.0 Cr -3.1% -1.6% 47.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹175,196.0 Cr -1.2% -5% 29.4% Stock Analytics
CIPLA ₹107,746.0 Cr 2.3% -2% -13.2% Stock Analytics
DR REDDYS LABORATORIES ₹101,894.0 Cr 2.2% 6.2% -2.5% Stock Analytics


STRIDES PHARMA SCIENCE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE

-2.1%

-7.9%

27.2%

SENSEX

3.8%

-0.6%

-9.1%


You may also like the below Video Courses